PHARM.ASPHARM.ASAMS
Loading
Book Value/Share Growth TrendStable
Percentile Rank67
3Y CAGR+32.6%
5Y CAGR-3.5%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
+32.6%/yr
vs -21.3%/yr prior
5Y CAGR
-3.5%/yr
Recent acceleration
Acceleration
+53.9pp
Accelerating
Percentile
P67
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 qtr
Consecutive declineStable
| Period | Value |
|---|---|
| Q3 2025 | 10.48% |
| Q2 2025 | 11.27% |
| Q1 2025 | 7.72% |
| Q4 2024 | -14.50% |
| Q3 2024 | 41.18% |
| Q2 2024 | 0.80% |
| Q1 2024 | -5.87% |
| Q4 2023 | -13.93% |
| Q3 2023 | 24.61% |
| Q2 2023 | 0.08% |
| Q1 2023 | -2.59% |
| Q4 2022 | 3.44% |
| Q3 2022 | 4.49% |
| Q2 2022 | 2.91% |
| Q1 2022 | 5.72% |
| Q4 2021 | 0.00% |
| Q2 2021 | 6.03% |
| Q1 2021 | 1.56% |
| Q4 2020 | 14.85% |
| Q3 2020 | 12.93% |
| Q2 2020 | 12.51% |
| Q1 2020 | 8.75% |
| Q4 2019 | 18.46% |
| Q3 2019 | 6.18% |
| Q2 2019 | 13.59% |
| Q1 2019 | 9.80% |
| Q4 2018 | 26.19% |
| Q3 2018 | 7.76% |
| Q2 2018 | 32.76% |
| Q1 2018 | 57.01% |
| Q4 2017 | 209.26% |
| Q3 2017 | -18.57% |
| Q2 2017 | -74.98% |
| Q1 2017 | 7.06% |
| Q4 2016 | 71.86% |
| Q3 2016 | -25.93% |
| Q2 2016 | -15.91% |
| Q1 2016 | -7.85% |
| Q4 2015 | -9.44% |
| Q3 2015 | -11.28% |